NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that it will hold its 2022 annual general meeting of shareholders at its London office … [Read more…]
Third quarter revenue of $712 million; (17)% reported growth Pro forma* total revenue of $1,033 million; 9% pro forma non-COVID organic growth Third quarter GAAP EPS from continuing operations of $0.55; pro forma adjusted EPS of $1.51 Initiates fourth quarter and updates full year pro forma guidance WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE: PKI), a global … [Read more…]
FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2022. Third Quarter End Results Third quarter net sales for 2022 were $35.5 million, a decrease of $3.9 million, or 10.0%, as compared to … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biosimilar Hormones Global Market Report 2022: By Type, By Application, By Distribution” report has been added to ResearchAndMarkets.com’s offering. The global biosimilar hormones market is expected to grow from $1.74 billion in 2021 to $2.31 billion in 2022 at a compound annual growth rate (CAGR) of 32.5%. The growth is mainly due to … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Healthcare/Medical Simulation Market by Product and Service (Anatomical Models, Patient Simulators (High Fidelity, Low Fidelity), Task Trainer, Surgical Simulators, Software, Services), End User (Academic Institutes, Hospital) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global medical simulation market is projected to reach USD 4.2 billion by 2027 from … [Read more…]
Sander van Deventer is co-founder and former Chief Technology Officer of the Company Elena Ritsou assumes role of Chief Corporate Officer Barbara Sanders is promoted to Chief Technology Officer Industry veteran Frank Walsh joins as an Independent Board Member AMSTERDAM–(BUSINESS WIRE)–VectorY Therapeutics, a biotech company developing innovative vectorized antibody approaches for the treatment of neurodegenerative … [Read more…]
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Two additional Breakthrough Device Designations granted by U.S. FDA for ARC Therapy Strong financial position with €70 million in cash and cash equivalents as of September 30, 2022, expected to fund operations through year-end 2024 Conference … [Read more…]
RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the pricing of its underwritten public offering of 10,526,316 shares of its common stock at a public offering price of $4.75 per share, and, to certain investors in lieu of common … [Read more…]
The gift from the Ryan and Ashley Smith Foundation, in partnership with 5 For The Fight, continues a decades-long commitment to helping end cancer SALT LAKE CITY–(BUSINESS WIRE)–The Ryan and Ashley Smith Foundation today announced a $20 million donation to Utah’s Intermountain Primary Children’s Hospital, a 100-year-old, top-ranked pediatric hospital. The money will help power … [Read more…]
Transaction Highlights Walgreens Boots Alliance announces offering of 10 million shares held in AmerisourceBergen Corporation through a registered public offering and a concurrent share repurchase by AmerisourceBergen of approximately $500 million Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown and the continued support of the company’s strategic priorities, including acquisitions DEERFIELD, … [Read more…]
